CNMD
CONMED CorporationNYSEHealthcare$34.79-2.08%ClosedMarket Cap: $1.08B
As of 2026-04-06
Valuation
P/E (TTM)
22.90
PEG
—
P/B
1.02
P/S
0.77
EV/EBITDA
10.48
DCF Value
$135.14
FCF Yield
14.3%
Div Yield
1.2%
Margins & Returns
Gross Margin
54.6%
Operating Margin
7.5%
Net Margin
3.4%
ROE
4.7%
ROA
2.0%
ROIC
3.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $373.2M | 58.5% | $36.6M | $16.7M | $0.54 | — |
| FY 2025 | $1.37B | 54.6% | $102.6M | $47.1M | $1.51 | $0.60 |
| Q3 2025 | $337.9M | 49.2% | $11.9M | $2.9M | $0.09 | $0.20 |
| Q2 2025 | $342.3M | 55.0% | $38.2M | $21.4M | $0.69 | $0.20 |
| Q1 2025 | $321.3M | 55.3% | $16.0M | $6.0M | $0.19 | $0.20 |
| Q4 2024 | $345.9M | 57.3% | $52.5M | $33.8M | $1.08 | $0.20 |
| FY 2024 | $1.31B | 56.1% | $200.3M | $132.4M | $4.26 | $0.80 |
| Q3 2024 | $316.7M | 56.5% | $65.7M | $49.0M | $1.57 | $0.20 |
| Q2 2024 | $332.1M | 55.3% | $47.1M | $30.0M | $0.96 | $0.20 |
| Q1 2024 | $312.3M | 55.1% | $35.0M | $19.7M | $0.63 | $0.20 |
| Q4 2023 | $327.0M | 55.7% | $50.2M | $33.1M | $1.05 | $0.20 |
| FY 2023 | $1.24B | 54.3% | $120.6M | $64.5M | $2.04 | $0.80 |